NCT06432543

Brief Summary

Purpose of research The purpose of this study was to demonstrate that polyethylene (Vitamin E-containing polyethylene), a newly introduced biomaterial for tibial inserts in hip replacement surgery and widely used clinically, but whose mid- to long-term clinical results are still unknown, is superior to conventional polyethylene in vivo. The aim of this project is to conduct an international multi-center joint research study to determine whether polyethylene wear debris production can be reduced in the future, using an in vivo polyethylene wear debris analysis method that the investigators developed as a method that can provide early feedback.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
32mo left

Started Jun 2024

Longer than P75 for all trials

Geographic Reach
2 countries

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress42%
Jun 2024Dec 2028

First Submitted

Initial submission to the registry

May 16, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 29, 2024

Completed
3 days until next milestone

Study Start

First participant enrolled

June 1, 2024

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

January 20, 2025

Status Verified

January 1, 2025

Enrollment Period

3.6 years

First QC Date

May 16, 2024

Last Update Submit

January 16, 2025

Conditions

Keywords

Polyethylene wear particleTotal hip arthroplasty

Outcome Measures

Primary Outcomes (4)

  • Number of polyethylene wear particles

    counts / g (tissue sample)

    When tissue sample was collected during THA revision surgery

  • Equivalent circle diameter of polyethylene wear particles

    equivalent circle diameter \[㎛\]

    When tissue sample was collected during THA revision surgery

  • Aspect ratio of polyethylene wear particles

    aspect ratio

    When tissue sample was collected during THA revision surgery

  • Roundness of polyethylene wear particles

    roundness

    When tissue sample was collected during THA revision surgery

Secondary Outcomes (8)

  • Body mass index

    When tissue sample was collected during THA revision surgery

  • Hip joint flexion angle

    When tissue sample was collected during THA revision surgery

  • Hip joint exertion angle

    When tissue sample was collected during THA revision surgery

  • Hip joint adduction angle

    When tissue sample was collected during THA revision surgery

  • Hip joint abduction angle

    When tissue sample was collected during THA revision surgery

  • +3 more secondary outcomes

Study Arms (3)

polyethylene containing Vitamin E

polyethylene containing Vitamin E

Device: polyethylene

conventional polyethylene (no highly cross-linking)

conventional polyethylene (no highly cross-linking)

Device: polyethylene

conventional polyethylene (with highly cross-linking)

conventional polyethylene (with highly cross-linking)

Device: polyethylene

Interventions

No intervention as this is an observational study

conventional polyethylene (no highly cross-linking)conventional polyethylene (with highly cross-linking)polyethylene containing Vitamin E

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing revision hip arthroplasty within the study period

You may qualify if:

  • Patients undergoing revision hip arthroplasty within the study period
  • Patients over 20 years old
  • Patients who have received a sufficient explanation, have sufficient understanding, and have given their free written consent.
  • Patients who have passed 2 years or more since their first total hip arthroplasty

You may not qualify if:

  • \. Patients who are judged to be unsuitable as research subjects by the research physician

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Mayo Clinic

Rochester, Minnesota, 55905, United States

NOT YET RECRUITING

Osaka Metropolitan University

Osaka, 5458585, Japan

RECRUITING

Related Publications (3)

  • Iwakiri K, Iwaki H, Kobayashi A, Minoda Y, Kagiyama H, Kadoya Y, Takaoka K. Characteristics of Hylamer polyethylene particles isolated from peri-prosthetic tissues of failed cemented total hip arthroplasties. J Biomed Mater Res B Appl Biomater. 2008 Apr;85(1):125-9. doi: 10.1002/jbm.b.30924.

  • Hata K, Minoda Y, Ikebuchi M, Mizokawa S, Ohta Y, Miyazaki N, Miyake Y, Nakamura H. In vivo wear particles of remelted highly crosslinked polyethylene after total hip arthroplasty: report of four cases. J Mater Sci Mater Med. 2015 Mar;26(3):133. doi: 10.1007/s10856-015-5472-9. Epub 2015 Feb 25.

  • Minoda Y, Kobayashi A, Sakawa A, Aihara M, Tada K, Sugama R, Iwakiri K, Ohashi H, Takaoka K. Wear particle analysis of highly crosslinked polyethylene isolated from a failed total hip arthroplasty. J Biomed Mater Res B Appl Biomater. 2008 Aug;86(2):501-5. doi: 10.1002/jbm.b.31048.

Biospecimen

Retention: SAMPLES WITHOUT DNA

The pericapsular tissue, which is removed during surgery

Study Officials

  • Yukihide Minoda, MD, PhD

    Osaka Metropolitan University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 16, 2024

First Posted

May 29, 2024

Study Start

June 1, 2024

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2028

Last Updated

January 20, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations